Profile - To The Moon

yolopororo

Posts · 0Posts · 0
Following · 0Following · 0
Followers · 0Followers · 0

- yolopororoyolopororo
  ·2021-07-16
  cool!
  Sorry, this post has been deleted
  1.85K Comment
  5
  Share
  Report
- yolopororoyolopororo
  ·2021-07-16
  nice!
  Drugmaker GSK plans $550 mln expansion of England R&D facility
  July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences
  Drugmaker GSK plans $550 mln expansion of England R&D facility
  2.09K Comment
  2
  Share
  Report
- yolopororoyolopororo
  ·2021-07-16
  jdidnsn
  1.87K Comment
  Like
  Share
  Report
- yolopororoyolopororo
  ·2021-07-14
  biugb
  1.81K Comment
  Like
  Share
  Report
- yolopororoyolopororo
  ·2021-07-13
  hgthbkob
  2.00K Comment
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4088951070418820","uuid":"4088951070418820","gmtCreate":1625852715360,"gmtModify":1625852715360,"name":"yolopororo","pinyin":"yolopororo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":6,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":170826266,"gmtCreate":1626421618855,"gmtModify":1703759848125,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"cool!","listText":"cool!","text":"cool!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170826266","repostId":"1135598731","repostType":4,"isVote":1,"tweetType":1,"viewCount":1851,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170828277,"gmtCreate":1626421555899,"gmtModify":1703759846982,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"nice!","listText":"nice!","text":"nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170828277","repostId":"2151508331","repostType":4,"repost":{"id":"2151508331","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626420022,"share":"https://ttm.financial/m/news/2151508331?lang=en_US&edition=fundamental","pubTime":"2021-07-16 15:20","market":"us","language":"en","title":"Drugmaker GSK plans $550 mln expansion of England R&D facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2151508331","media":"Reuters","summary":"July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences","content":"<p>July 16 (Reuters) - Britain's GlaxoSmithKline&nbsp;on Friday laid out plans to set up a new life sciences campus within its R&amp;D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.</p>\n<p>The London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.</p>\n<p>GSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.</p>\n<p>\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.</p>\n<p>GSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.</p>\n<p>Stevenage is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of GSK's two global R&amp;D hubs and houses the UK's largest cell and gene therapy cluster.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Drugmaker GSK plans $550 mln expansion of England R&D facility</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDrugmaker GSK plans $550 mln expansion of England R&D facility\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-16 15:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 16 (Reuters) - Britain's GlaxoSmithKline&nbsp;on Friday laid out plans to set up a new life sciences campus within its R&amp;D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.</p>\n<p>The London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.</p>\n<p>GSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.</p>\n<p>\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.</p>\n<p>GSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.</p>\n<p>Stevenage is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of GSK's two global R&amp;D hubs and houses the UK's largest cell and gene therapy cluster.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151508331","content_text":"July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.\nThe London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.\nGSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.\n\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.\nGSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.\nStevenage is one of GSK's two global R&D hubs and houses the UK's largest cell and gene therapy cluster.","news_type":1,"symbols_score_info":{"GSK":0.9}},"isVote":1,"tweetType":1,"viewCount":2092,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170821302,"gmtCreate":1626421498706,"gmtModify":1703759844368,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"jdidnsn","listText":"jdidnsn","text":"jdidnsn","images":[{"img":"https://static.tigerbbs.com/fb26b4d096d8fd6591cd0e96ca407037","width":"1125","height":"1826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170821302","isVote":1,"tweetType":1,"viewCount":1867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":144863347,"gmtCreate":1626275476089,"gmtModify":1703756985674,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"biugb","listText":"biugb","text":"biugb","images":[{"img":"https://static.tigerbbs.com/8367cbe2590465b61729e330067a2a25","width":"1125","height":"1826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/144863347","isVote":1,"tweetType":1,"viewCount":1810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":145937537,"gmtCreate":1626185735229,"gmtModify":1703755107333,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"hgthbkob&nbsp;","listText":"hgthbkob&nbsp;","text":"hgthbkob","images":[{"img":"https://static.tigerbbs.com/6c5db8d7e62f44b893d9b05c22677dba","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145937537","isVote":1,"tweetType":1,"viewCount":2004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}